Access to Prescription Digital Therapeutics Act of 2023

Bill 118 hr 1458, also known as the Access to Prescription Digital Therapeutics Act of 2023, aims to increase access to digital therapeutics for patients in need of medical treatment. Digital therapeutics are software-based interventions that are designed to treat various medical conditions, such as mental health disorders, chronic diseases, and substance abuse.

The bill proposes to establish a framework for the regulation and approval of prescription digital therapeutics by the Food and Drug Administration (FDA). This framework would ensure that these digital therapeutics meet the same safety and efficacy standards as traditional prescription medications.

Additionally, the bill seeks to expand insurance coverage for digital therapeutics, making it easier for patients to access these treatments without facing financial barriers. This would help ensure that patients have access to a wider range of treatment options, including innovative digital therapies that may be more convenient and effective than traditional treatments. Overall, the Access to Prescription Digital Therapeutics Act of 2023 aims to improve patient access to cutting-edge digital therapies while maintaining high standards for safety and efficacy. By expanding insurance coverage and establishing a regulatory framework for digital therapeutics, this bill has the potential to revolutionize the way medical conditions are treated in the United States.